Spago Nanomedical AB Logo

Spago Nanomedical AB

SPAGO | ST

Overview

Corporate Details

ISIN(s):
SE0004899474 (+2 more)
LEI:
549300DNLTVJ4OGO5X40
Country:
Sweden
Address:
Scheelevägen 22, 223 63 Lund
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Spago Nanomedical is a clinical-stage nanomedicine company developing products for improved diagnostics and treatment of life-threatening diseases. The company leverages a proprietary platform of polymeric materials to create precision medical solutions. Its development pipeline is led by two key projects: SpagoPix and Tumorad®. SpagoPix (candidate drug SN132D) is a contrast agent designed to enhance the precision of MRI in detecting tumors and abnormalities in organs like the breast, liver, and pancreas. Tumorad® (candidate drug SN201) is a targeted radionuclide therapy being developed for the treatment of various cancers, which has shown favorable tumor accumulation in preclinical studies. The company's focus is on improving patient outcomes through more precise and effective diagnostics and therapies.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Spago Nanomedical AB. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Spago Nanomedical AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Spago Nanomedical AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
ONCODESIGN Logo
Develops precision cancer therapies and diagnostics targeting resistance and metastasis.
France ALONC
Oncodesign Precision Medicine S.A Logo
Develops therapies & diagnostics for resistant and metastatic cancers.
France ALOPM
Oncoinvent ASA Logo
Developing alpha-emitting radiopharmaceuticals like Radspherin® for localized cancer treatment.
Norway OCIN
OncoZenge AB Logo
Developing a non-opioid lozenge for oral pain relief in cancer patients.
Sweden ONCOZ
Onxeo Logo
Developing precision therapies for complex diseases using a proprietary single-domain antibody platform.
France ALONX
OPTIBIOTIX HEALTH PLC Logo
Develops microbiome-modulating ingredients and supplements to manage chronic lifestyle diseases.
United Kingdom OPTI
Oramed Pharmaceuticals Inc. Logo
Developing oral drug delivery systems to replace injections, like an oral insulin capsule.
Israel ORMP
Oryzon Genomics S.A. Logo
Advancing epigenetic therapeutics for oncology and central nervous system disorders.
Spain ORY
OSE Immunotherapeutics Logo
Developing first-in-class immunotherapies for immuno-oncology and immuno-inflammation.
France OSE
Ovoca Bio Plc Logo
Clinical-stage biopharma developing novel treatments for female sexual dysfunction.
Ireland OVXA